|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號(hào)：C781405 |
| 產(chǎn)品名稱：CP-481715 |
| 產(chǎn)品CAS：212790-31-3 |
| 規(guī)格含量：5mg |
| 產(chǎn)品價(jià)格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號(hào): |
C781405 |
| 名稱: |
CP-481715 |
| 別名: |
N-[(1S,2S,4R)-4-(Aminocarbonyl)-1-[(3-fluorophenyl)methyl]-2,7-dihydroxy-7-methyloctyl]-2-quinoxalinecarboxamide; |
| CAS號(hào): |
212790-31-3 |
| 分子式: |
C??H??FN?O? |
| 分子量: |
482.55 |
| 類別: |
Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
CP-481715 is used in the discovery and in the development of maraviroc, a CCR5 anatagonist for the treatment of HIV. |
| 參考文獻(xiàn) |
|
|
|
|
?您的位置：
